FDA OKs Merck ' s Keytruda for head and neck cancer

The approval is based on a late-stage trial in which Keytruda showed a significant improvement in overall survival in cancer patients.
Source: PharmaManufacturing.com - Category: Pharmaceuticals Source Type: news